Cross-cultural validation of a short-form of the Vitiligo Impact Patient scale (VIPs) - 11/10/19
Abstract |
Background |
There is a lack of short-form questionnaires evaluating the burden of vitiligo according to skin phototype.
Objective |
To develop and validate a 12-item short-form of the Vitiligo Impact Patient scale (VIPs) that takes into account skin phototype.
Methods |
Multicenter, prospective, cross-sectional study conducted in France (Créteil and Bordeaux) and the US (Worcester, Massachusetts, and Dallas, Texas).
Results |
In total, 891 patients completed the questionnaire. Of these, 509 patients belonged to the French Development sample—313 with dark skin (DS) (phototypes IV to VI) and 196 with fair skin (FS) (phototypes I to III). The US validation sample comprised 382 patients—113 DS and 269 FS. There was a very high correlation between VIPs-FS and its 12-item short-form, VIPs-12-FS, in both the development and validation samples (respectively, rho = 0.96, P < .0001 and rho = 0.98, P < .0001). Similarly, the correlations between VIPs-DS and its short-form, VIPs-12-DS, in both the development and validation samples were very high (respectively, rho = 0.95, P < .0001 and rho = 0.96, P < .0001).
Limitations |
Responsiveness of the 12-item short-forms should be confirmed.
Conclusions |
These data enabled the development and validation of 12-item short-forms of the VIPs questionnaires for fair (VIPs-12-FS) and dark (VIPs-12-DS) skin.
Le texte complet de cet article est disponible en PDF.Key words : burden, patient reported outcomes, quality of life short-form, questionnaire, vitiligo, vitiligo impact scale
Abbreviations used : DS, FS, PRO, VIPs
Plan
Funding sources: Supported in part by Pfizer, who had no role in the design and conduct of the study; collection, management, analysis, and interpretation of data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication. |
|
Conflicts of interest: None disclosed. |
Vol 81 - N° 5
P. 1107-1114 - novembre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?